The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Carcinosin
Carcinosin · HUMAN BREAST TUMOR CELL 30 [hp_C]/mL · Liquid · Oral · Deseret Biologicals, Inc.
NDC 43742-0676-01 · 30 mL in 1 BOTTLE, DROPPER · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Carcinosin (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Energique, Inc. | HUMAN BREAST TUMOR CELL 12 [hp_X]/mL | Jul 15, 2026 | Sep 3, 2026 |
| Deseret Biologicals, Inc. | HUMAN BREAST TUMOR CELL 30 [hp_C]/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Carcinosin — NDC 43742-0676-01," retrieved September 3, 2026, https://drugdashboards.com/drug/43742067601.
Free to cite with attribution — see how the data is put together.